Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.
Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.
复制标题
DOI:
10.1158/2326-6066.cir-17-0131
复制
发表时间:
2017-11
影响因子:
10.1
通讯作者:
Gallimore A
中科院分区:
文献类型:
--
作者:
Colbeck EJ;Jones E;Hindley JP;Smart K;Schulz R;Browne M;Cutting S;Williams A;Parry L;Godkin A;Ware CF;Ager A;Gallimore A
T-cell infiltration into tumors represents a critical bottleneck for immune-mediated control of cancer. We previously showed that this bottleneck can be overcome by depleting immunosuppressive Foxp3+ regulatory T cells (Tregs), a process which can increase frequencies of tumor-infiltrating lymphocytes (TILs) through promoting development of specialized portals for lymphocyte entry, namely high endothelial venules (HEVs). In this paper, we used a carcinogen-induced tumor model, that allows for co-evolution of the tumor microenvironment and the immune response, to demonstrate that Treg depletion not only results in widespread disruption to HEV networks in lymph nodes (LNs) but activates CD8+ T cells, which then drive intratumoral HEV development. Formation of these vessels contrasts with ontogenic HEV development in LNs in that the process is dependent on TNF receptor and independent of lymphotoxin β receptor-mediated signaling. These intratumoral HEVs do not express the chemokine CCL21, revealing a previously undescribed intratumoral blood vessel phenotype. We propose a model where Treg depletion enables a self-amplifying loop of T-cell activation, which promotes HEV development, T-cell infiltration, and ultimately, tumor destruction. The findings point to a need to test for HEV development as part of ongoing clinical studies in patients with cancer.
影响因子:
6.4
作者:
Ondondo, Beatrice;Jones, Emma;Hindley, James;Cutting, Scott;Smart, Kathryn;Bridgeman, Hayley;Matthews, Katherine K.;Ladell, Kristin;Price, David A.;Jackson, David G.;Godkin, Andrew;Ager, Ann;Gallimore, Awen
通讯作者:
Gallimore, Awen